共 341 条
[7]
ORAL PROTEIN KINASE C β INHIBITION USING RUBOXISTAURIN Efficacy, Safety, and Causes of Vision Loss Among 813 Patients (1,392 Eyes) with Diabetic Retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein kinase C β Inhibitor-Diabetic Retinopathy Study 2
[J].
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,
2011, 31 (10)
:2084-2094
[10]
Amoaku M., 2021, Int. J. Transl. Med., V2, P1, DOI 10.3390/IJTM2010001